In neurodegenerative disorders (ALS and FTLD), the mutation p62G427R abolishes phosphorylation of Ser351(Ser349 in human) and disrupts p62-mediated selective autophagy, which contributes to impaired clearance of misfolded protein aggregates and accelerates disease progression [108]. Here, SQSTM1 is linked to amyotrophic lateral sclerosis.